Cargando…
The active metabolite of leflunomide, A77-1726, increases proliferation of human synovial fibroblasts in presence of IL-1β
Autores principales: | Magne, D, Mezin, F, Palmer, G, Guerne, PA |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833744/ http://dx.doi.org/10.1186/ar1103 |
Ejemplares similares
-
The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes
por: Palmer, Gaby, et al.
Publicado: (2004) -
Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts
por: Palmer, G, et al.
Publicado: (2003) -
The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function
por: Kirsch, Bernhard M, et al.
Publicado: (2005) -
Therapeutic response to leflunomide in combo therapy and monotherapy is associated to serum teriflunomide (A77 1726) levels
por: Fajardo-Robledo, Nicte S., et al.
Publicado: (2022) -
The active metabolite of leflunomide, A77 1726, attenuates inflammatory arthritis in mice with spontaneous arthritis via induction of heme oxygenase-1
por: Moon, Su-Jin, et al.
Publicado: (2017)